Compton Wealth Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,786
Closed -$683K 86
2023
Q3
$683K Sell
9,786
-275
-3% -$19.5K 0.23% 60
2023
Q2
$696K Buy
10,061
+770
+8% +$54.8K 0.23% 59
2023
Q1
$690K Sell
9,291
-1
-0% -$84 0.24% 58
2022
Q4
$866K Sell
9,292
-226
-2% -$21.8K 0.34% 57
2022
Q3
$908K Buy
9,518
+1,125
+13% +$111K 0.39% 53
2022
Q2
$778K Buy
+8,393
New +$819K 0.34% 60
2019
Q1
Sell
-3,590
Closed -$235K 70
2018
Q4
$235K Buy
+3,590
New +$268K 0.12% 66

Other funds holding CVS

Compton Wealth Advisory Group's CVS Position: Q4 2023 in Review

Compton Wealth Advisory Group sold out of CVS Health (CVS) in Q4 2023, closing a stake of 9,786 shares — an estimated $683K sold.

Compton Wealth Advisory Group first reported a position in CVS in Q4 2018 and held it in 7 quarters. The position peaked at $908K in Q3 2022. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Compton Wealth Advisory Group reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Compton Wealth Advisory Group sold 9,786 CVS Health shares in Q4 2023, an estimated $683K.
  • Compton Wealth Advisory Group first reported a position in CVS Health in Q4 2018 and held it in 7 quarters.
  • Compton Wealth Advisory Group's CVS Health position peaked at $908K in Q3 2022.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Compton Wealth Advisory Group's 13F filing for Q4 2023, filed 19 Jan 2024.